IL3 and chronic myelogenous leukemia, BCR-ABL1 positive: Another study engineered sEVs derived from HEK293T cells with a fragment of IL-3 to target overexpressed IL-3 receptor (IL-3R) in chronic myeloid leukaemia (CML) cells.